查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2106671

動脈粥狀硬化斑塊切除術器材：市場洞察、競爭格局與市場預測 - 2034 年

Atherectomy Devices - Market Insights, Competitive Landscape, and Market Forecast - 2034
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

概述：

  • 2025年，動脈粥狀硬化斑塊切除術器械市場規模估計為11.2億美元，預計到2034年將達到23.4億美元。該成長是由冠狀動脈和周邊動脈疾病在全球範圍內日益嚴重的負擔、微創血運重建療法的加速發展以及定向、旋轉、軌道和雷射斑塊清除技術的不斷創新所推動的。
  • 全球動脈粥狀硬化斑塊切除術器械市場預計在2026年至2034年的預測期內將以 8.5%的CAGR成長。
  • 依產品類別分類，定向斑塊動脈粥狀硬化斑塊切除術裝置因其在治療周邊動脈和冠狀動脈病變方面的高度多功能性，到2025年佔市場佔有率的40%左右，推動動脈粥狀硬化斑塊切除術裝置市場的發展。
  • 從應用角度來看，周邊動脈疾病，並推動了動脈粥狀硬化斑塊切除術器械市場的發展。
  • 依最終用戶分類，在導管室基礎設施和多學科介入團隊的支持下，到2025年，醫院部門佔市場佔有率的65%左右，主導動脈粥狀硬化斑塊切除術設備市場。
  • 到2025年，北美佔全球市場佔有率的約 42%，推動全球動脈粥狀硬化斑塊切除術器械市場的銷售，並在全球佔據最高的市場佔有率。

動脈動脈粥狀硬化斑塊切除術是一種微創的導管介入手術，它透過機械方式清除病變冠狀動脈和周邊動脈中的動脈粥狀硬化斑塊、鈣化和血栓，恢復血管腔通暢，而無需完全依賴球囊擴張或永久性支架植入。動脈粥狀斑塊動脈粥狀硬化斑塊切除術裝置經過專門設計，可用於切割、刮除、拋光或光消融斑塊，並開發為定向、旋轉、軌道或雷射（光消融）系統。每種裝置都適用於不同的病變形態，從柔軟的偏心斑塊到高度鈣化的瀰漫性病變。在冠狀動脈疾病、周邊動脈疾病和支架內再血管再阻塞，經常會遇到難以透過傳統血管成形術處理的嚴重鈣化和纖維化病變，因此介入性心臟病專家和血管專家越來越依賴動脈動脈粥狀硬化斑塊切除術作為血管準備和獨立的病變清除手段。該市場依產品可細分為定向、旋轉、軌道和雷射動脈粥狀硬化斑塊切除術裝置；依應用可細分為冠狀動脈疾病、周邊動脈疾病和血管再阻塞；依終端用戶可細分為醫院、專科診所和其他門診機構。受全球心血管疾病盛行率上升、糖尿病患者年齡成長和數量增加、門診和以護理為基礎的介入治療模式的轉變以及影像整合和多重模式裝置的快速技術進步的推動，動脈粥狀硬化斑塊切除術裝置製造商已成為現代介入性心臟病學和血管外科生態系統中不可或缺的合作夥伴。

動脈動脈粥狀硬化斑塊切除術器械市場的主要市場促進因素

  • 全球心血管疾病負擔日益加重，推動了心血管疾病的需求。據估計，到2024年，全球有 2億人患有冠狀動脈疾病，另有數百萬人患有周邊動脈疾病或中風。
  • 周邊動脈疾病，尤其是在老年人、糖尿病患者和高血壓患者中，這推動了對有效且持久的斑塊清除解決方案的需求不斷成長。
  • 與開放性手術進行重組手術相比，微創手術越來越受歡迎，並且由於其住院時間短、恢復快、併發症率低等優點，這種設備的採用加速。
  • 影像導引動脈粥狀硬化斑塊切除術、血管內超音波與光學同調斷層掃描（OCT）的融合以及雷射與取石術相結合的平台等技術的不斷進步，提高手術的精確性和安全性。
  • 由於監管部門加快了核准速度，Auryon動脈粥狀硬化斑塊切除術系統的適應症範圍日益擴大，其中包括 AngioDynamics 於2024年 9月獲得的CE 標誌，用於治療周邊動脈疾病（PAD）、嚴重下肢缺血和支架內再血管再阻塞。
  • 心臟介入醫學在門診和日間手術中心的擴展，增加了接受動脈粥狀硬化斑塊切除術術的機會，並降低了手術費用。
  • 包括Abbott收購心血管系統公司在內的策略整合，凸顯了動脈粥狀硬化斑塊切除術技術的戰略價值，預計對創新的投資將持續到2034年。

推動動脈粥狀硬化斑塊切除術器械市場成長的因素

市場促進因素

冠狀動脈疾病和周邊動脈疾病的全球負擔日益加重

推動動脈粥狀動脈粥狀硬化斑塊切除術器械市場成長的最主要因素是全球心血管疾病負擔的日益惡化。到2024年，全球有2億人患有冠狀動脈疾病，另有數百萬人受到周邊動脈疾病或中風的影響。老年人和糖尿病患者常出現高度鈣化的動脈粥狀硬化斑塊，這些斑塊通常難以透過傳統的球囊血管成形術清除，需要在根治性治療前進行機械清除。隨著高血壓、糖尿病和肥胖症在全球範圍內的患病率持續上升，預計推動動脈粥樣動脈粥狀硬化斑塊切除術手術的潛在疾病負擔將穩步增加，支撐市場成長直至2034年。

人們越來越傾向選擇微創血管重建療法

在患者和醫師中，微創導管介入治療越來越受到青睞，逐漸取代了開胸心臟繞道手術。動脈粥狀硬化斑塊切除術具有顯著的臨床優勢，包括縮短住院時間、加速復健、減輕手術帶來的身體負擔，並且在許多情況下可以避免永久性支架植入。特別是定向斑塊動脈粥狀硬化斑塊切除術，它透過選擇性地去除斑塊而不植入永久性植入，降低了血管再阻塞等併發症的風險。隨著門診和以護理為基礎的心臟介入治療的不斷擴展，斑塊動脈粥狀硬化斑塊切除術的技術和經濟優勢預計將在預測期內推動其廣泛應用。

市場限制因素

儘管動脈粥狀硬化斑塊切除術術市場發展動力強勁，但仍面臨諸多限制因素。動脈動脈粥狀硬化斑塊切除術系統及相關手術的高成本限制了其在價格敏感市場和預算有限的醫療機構中的普及。手術併發症的風險，例如血管穿孔、血管撕裂和術後再血管再阻塞，也使得醫生在某些患者群體中不願採用該手術。此外，該市場還面臨來自成熟且低成本的替代療法的激烈競爭，例如球囊血管成形術、支架置入術和藥物釋放型球囊，這些療法均擁有豐富的長期臨床資料支持。接受過動脈粥狀硬化斑塊切除術術訓練的介入性心臟病專家和血管外科醫生數量有限，也限制了該技術的普及，尤其是在發展中地區。此外，法律規範的碎片化和不斷變化也增加了製造商在多個市場尋求批准的複雜性。儘管疾病負擔加重和微創治療偏好等潛在促進因素依然強勁，但各國償付機制的差異進一步減緩了該技術的普及速度。

目錄

第1章 動脈粥狀硬化斑塊切除術器械市場：引言

  • 調查範圍
  • 市場區隔
  • 市場先決條件

第2章 動脈粥狀硬化斑塊切除術器械市場：執行摘要

  • 市場概覽

第3章 動脈粥狀硬化斑塊切除術器械市場：關鍵因素分析

  • 動脈動脈粥狀硬化斑塊切除術器械市場：市場促進因素
    • 冠狀動脈疾病和周邊動脈疾病的全球負擔日益加重
    • 人們越來越傾向於選擇微創血管重組手術。
    • 技術進步及其與醫學影像技術的融合
    • 監管機構加速核准並擴大使用範圍
  • 動脈動脈粥狀硬化斑塊切除術器械的市場限制與挑戰
    • 設備和手術高成本
    • 併發症和血管再阻塞的風險
    • 替代療法的競爭
  • 動脈動脈粥狀硬化斑塊切除術器械市場：市場機會
    • 用於將聯合治療的設備。
    • 新興市場和門診服務的拓展

第4章 人工智慧、地緣政治、貿易與經濟趨勢

第5章 監理分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第6章 波特五力分析

第7章 動脈動脈粥狀硬化斑塊切除術器材市場評估

  • 依產品
    • 定向斑塊動脈粥狀硬化斑塊切除術裝置
    • 旋轉式動脈粥狀硬化斑塊切除術裝置
    • 軌道動脈粥狀硬化斑塊切除術裝置
    • 雷射動脈動脈粥狀硬化斑塊切除術裝置
  • 依用途
    • 缺血性心臟疾病
    • 周邊動脈疾病
    • 支架內再血管再阻塞
  • 依最終用戶
    • 醫院
    • 專科診所
    • 其他
  • 依地區
    • 北美洲
    • 歐洲
    • 亞太地區
    • 世界其他地區

第8章 動脈粥狀硬化斑塊切除術器材市場：競爭格局

  • 市場集中度與結構
  • 競爭定位與市場佔有率分析（加值服務）

第9章 動脈粥狀硬化斑塊切除術器材市場：新創企業資金籌措與投資趨勢

第10章 動脈動脈粥狀硬化斑塊切除術器材市場：公司概況與產品概況

  • Koninklijke Philips NV
  • Medtronic PLC
  • Boston Scientific Corporation
  • AngioDynamics Inc.
  • Abbott Laboratories
  • Avinger
  • BD
  • Ra Medical Systems
  • REX Medical
  • Cardio Flow, Inc.

第11章 KOL的觀點

第12章 專案方法

第13章 關於 DelveInsight

第14章 免責聲明與聯絡方式

Product Code: DIMDCL0313

Atherectomy Devices Market Summary

Overview:

  • The Atherectomy Devices market is estimated at USD 1.12 billion in 2025 and is projected to reach USD 2.34 billion by 2034. Growth is anchored in the rising global burden of coronary and peripheral artery disease, the accelerating shift toward minimally invasive revascularization, and continuous innovation in directional, rotational, orbital, and laser plaque-modification technology.
  • The global Atherectomy Devices market is growing at a CAGR of 8.5% during the forecast period from 2026 to 2034.
  • By product, the directional atherectomy devices segment dominated the Atherectomy Devices market with a ~40% share in 2025, owing to its versatility across both peripheral and coronary lesions.
  • By application, the peripheral artery disease segment dominated the Atherectomy Devices market with a ~50% share in 2025, reflecting the high prevalence of lower-extremity arterial disease.
  • By end-user, the hospitals segment dominated the Atherectomy Devices market with a ~65% share in 2025, supported by cath-lab infrastructure and multidisciplinary interventional teams.
  • North America dominated the global Atherectomy Devices market revenue with a ~42% share in 2025, representing the highest regional market share globally.

Atherectomy is a catheter-based, minimally invasive procedure that mechanically removes atherosclerotic plaque, calcium, and thrombus from diseased coronary and peripheral arteries to restore luminal patency without relying solely on balloon dilation or permanent stent placement. Atherectomy devices are purpose-built to cut, shave, sand, or photo-ablate plaque, and are engineered as directional, rotational, orbital, or laser (photo-ablative) systems, each suited to distinct lesion morphologies ranging from soft, eccentric plaque to densely calcified, diffuse disease. Because coronary artery disease, peripheral artery disease, and in-stent restenosis frequently involve heavily calcified or fibrotic lesions that resist conventional angioplasty, interventional cardiologists and vascular specialists increasingly turn to atherectomy as a vessel-preparation and standalone debulking tool. The market is organized by product across directional, rotational, orbital, and laser atherectomy devices; by application across coronary artery disease, peripheral artery disease, and in-stent restenosis; and by end-user across hospitals, specialty clinics, and other outpatient settings. Driven by the rising global prevalence of cardiovascular disease, an aging and increasingly diabetic population, the shift toward outpatient and ambulatory interventional care, and rapid technological advancement in imaging-integrated and multi-modality devices, atherectomy device manufacturers have become essential partners in the modern interventional cardiology and vascular surgery ecosystem.

Atherectomy Devices Market Key Growth Drivers

  • The rising global burden of cardiovascular disease is driving demand, with an estimated 200 million people worldwide affected by coronary heart disease as of 2024, alongside millions more living with peripheral artery disease and stroke.
  • The growing prevalence of peripheral artery disease, particularly among aging, diabetic, and hypertensive populations, is expanding demand for effective, durable plaque-removal solutions.
  • Increasing preference for minimally invasive procedures over open surgical revascularization is accelerating adoption, given shorter hospital stays, faster recovery, and reduced complication rates.
  • Continuous technological advancement, including image-guided atherectomy, intravascular ultrasound and optical coherence tomography integration, and combination laser/lithotripsy platforms, is improving procedural precision and safety.
  • Accelerating regulatory approvals and label expansions, including AngioDynamics' September 2024 CE Mark for the Auryon Atherectomy System covering PAD, critical limb ischemia, and in-stent restenosis, are widening addressable indications.
  • Expansion of outpatient and ambulatory surgical center-based interventional cardiology is broadening access and lowering the cost of atherectomy procedures.
  • Strategic consolidation, including Abbott's acquisition of Cardiovascular Systems, Inc., underscores the strategic value of atherectomy technology and is expected to sustain innovation investment through 2034.

Key Companies in Atherectomy Devices Market

The competitive landscape is led by the following active device manufacturers:

  • Koninklijke Philips N.V.
  • Medtronic PLC
  • Boston Scientific Corporation
  • AngioDynamics Inc.
  • Abbott Laboratories
  • Avinger
  • BD
  • Ra Medical Systems
  • REX Medical
  • Cardio Flow, Inc.

Factors Contributing to the Growth of the Atherectomy Devices Market

Market Drivers

Rising Global Burden of Coronary and Peripheral Artery Disease

The most powerful driver of the Atherectomy Devices market is the escalating global burden of cardiovascular disease. An estimated 200 million people worldwide were living with coronary heart disease as of 2024, and millions more were affected by peripheral artery disease and stroke. Atherosclerotic plaque buildup, often heavily calcified in elderly and diabetic patients, frequently resists conventional balloon angioplasty and requires mechanical debulking before definitive treatment. As the prevalence of hypertension, diabetes, and obesity continues to rise worldwide, the underlying disease burden driving atherectomy procedure volumes is expected to expand steadily, anchoring market growth through 2034.

Growing Preference for Minimally Invasive Revascularization

Patients and physicians increasingly favor minimally invasive, catheter-based interventions over open surgical bypass. Atherectomy offers meaningful clinical advantages, including shorter hospital stays, faster recovery, reduced peri-procedural trauma, and, in many cases, avoidance of permanent stent implantation. Directional atherectomy in particular allows selective plaque debulking without leaving a permanent implant behind, reducing the risk of complications such as in-stent restenosis. As outpatient and ambulatory interventional cardiology continues to expand, the procedural and economic advantages of atherectomy are expected to sustain adoption across the forecast period.

Market Restraints

Despite strong momentum, the Atherectomy Devices market faces material constraints. The high cost of atherectomy systems and associated procedures limits adoption in price-sensitive markets and budget-constrained healthcare settings. The risk of procedural complications, including vessel perforation, dissection, and post-procedure restenosis, tempers physician adoption in certain patient populations. The market also faces strong competition from established, lower-cost alternatives such as balloon angioplasty, stenting, and drug-coated balloons, which benefit from extensive long-term clinical data. A limited pool of interventional cardiologists and vascular surgeons trained in atherectomy techniques constrains adoption, particularly in developing regions, while fragmented and evolving regulatory frameworks across geographies add complexity for manufacturers seeking multi-market approval. Reimbursement variability across countries further tempers the pace of adoption, even as the underlying drivers of rising disease burden and minimally invasive preference remain firmly intact.

Atherectomy Devices Market Segment Analysis

The Atherectomy Devices Market by Product (Directional Atherectomy Devices, Rotational Atherectomy Devices, Orbital Atherectomy Devices, and Laser Atherectomy Devices), Application (Coronary Artery Disease, Peripheral Artery Disease, and In-Stent Restenosis), End-User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of World).

By Product

Dominant Subsegment: Directional Atherectomy Devices.

Dominant: Directional Atherectomy Devices ~ 40%

The directional atherectomy devices segment accounted for approximately 40% of the Atherectomy Devices market in 2025. Directional atherectomy is the leading product category because of its exceptional versatility and precision across both peripheral and coronary lesions. Its blade-within-housing design enables selective removal of eccentric and bulky plaque without significant damage to the healthy vessel wall, preparing the artery for subsequent balloon angioplasty or drug-coated balloon treatment and reducing the need for permanent stenting. Prominent directional atherectomy devices include Medtronic's HawkOne Directional Atherectomy System and Boston Scientific's Jetstream Atherectomy System. While rotational and orbital atherectomy are highly effective for heavily calcified lesions, and laser atherectomy is gaining traction in complex occlusions, the broad applicability and established safety profile of directional atherectomy devices secure their leading position. Laser atherectomy devices are projected to register the fastest growth of the forecast period, propelled by their unique photo-ablative mechanism, expanding use in chronic total occlusions and in-stent restenosis, and rising adoption as a vessel-preparation tool ahead of drug-coated balloon or stent placement.

By Application

Dominant Subsegment: Peripheral Artery Disease.

Dominant: Peripheral Artery Disease ~ 50%

The peripheral artery disease segment accounted for approximately 50% of the Atherectomy Devices market in 2025. Peripheral artery disease is the leading application because atherectomy is a first-line debulking strategy for femoropopliteal and below-the-knee lesions, particularly in patients with heavily calcified plaque where balloon angioplasty alone offers poor durability. Rising rates of diabetes and an aging population are directly expanding the pool of patients with critical limb ischemia and claudication requiring intervention. Coronary artery disease is the second-largest application, with rotational and orbital atherectomy increasingly used to prepare severely calcified coronary lesions ahead of stent deployment, supporting steady procedure volumes in cath labs worldwide. In-stent restenosis is the fastest-growing application, as laser and directional atherectomy are increasingly used to debulk neointimal and calcified tissue within previously stented segments, reducing the recurrence of restenosis and extending the durability of prior interventions. While in-stent restenosis is scaling quickly, the sheer prevalence and treatment volume of peripheral artery disease secures its leadership across the forecast period.

Atherectomy Devices Market Region Analysis

Dominant Region: North America

North America accounted for approximately 42% of the global Atherectomy Devices market revenue in 2025, representing the highest regional market share globally. The region's dominance reflects a high cardiovascular disease burden, advanced catheterization infrastructure, and favorable reimbursement conditions, particularly in the United States. Millions of U.S. adults are diagnosed with coronary heart disease, atrial fibrillation, and stroke each year, and an estimated 38.4 million people in the U.S. were living with diabetes in 2024, a major contributor to accelerated peripheral artery disease. North America also hosts a dense ecosystem of leading device manufacturers and a continuous pipeline of new product approvals, including the FDA's January 2025 clearance of the Rotarex Atherectomy System. Strong reimbursement, regulatory clarity, and a culture of continuous innovation anchor the region's continued leadership across the forecast period.

Fastest Growing Region: Asia-Pacific

Asia-Pacific is the fastest-growing region in the Atherectomy Devices market. The region's elevated CAGR is driven by a large and aging population, rapid healthcare infrastructure development, rising disposable income, and growing awareness of minimally invasive treatment options across China, India, Japan, South Korea, and Australia. China and India are making substantial investments in hospital infrastructure and training a new generation of interventional specialists, while Japan, Australia, and Singapore maintain well-established regulatory pathways that support faster product introductions. Rising rates of obesity, hypertension, and diabetes are fueling atherosclerosis prevalence across the region, and ongoing regulatory harmonization efforts are expected to streamline market entry for manufacturers. The combination of high disease burden, infrastructure build-out, and rising healthcare spending positions Asia-Pacific as the principal source of incremental growth over the forecast period.

Regional Commentary

North America

North America accounted for approximately 42% of the global Atherectomy Devices market revenue in 2025. The United States dominates on the strength of its high cardiovascular disease burden, advanced catheterization infrastructure, and favorable reimbursement environment, while a continuous pipeline of regulatory clearances and a dense manufacturer base reinforce its leadership.

Europe

Europe is a large and advanced regional market, supported by a high prevalence of cardiovascular disease within a rapidly aging population and a strong regional preference for minimally invasive procedures. Reimbursement policies vary across countries, with Germany, France, and the United Kingdom maintaining robust frameworks that encourage device adoption, while CE Mark approvals such as AngioDynamics' September 2024 clearance for the Auryon Atherectomy System continue to expand the region's treatment options.

Asia-Pacific

Asia-Pacific is the fastest-growing region, propelled by a large and aging population, rapid healthcare infrastructure build-out, and rising healthcare spending across China, Japan, India, South Korea, and Australia. Expanding hospital networks, growing patient awareness, and gradual regulatory harmonization are accelerating regional adoption of atherectomy technology.

Rest of World

The Rest of World region, spanning the Middle East, Africa, and South America, is an emerging growth frontier. Expanding healthcare infrastructure, rising diagnosis rates of coronary and peripheral artery disease, and gradual alignment of regulatory frameworks with global standards are broadening access, while international partnerships support the build-out of interventional cardiology capacity.

Atherectomy Devices Market Competitive Landscape

The Atherectomy Devices market is classified as Highly Consolidated. A small group of major players, including Medtronic, Boston Scientific, and Abbott, dominate the market through extensive R&D capabilities, broad product portfolios, and global distribution networks, while specialized innovators such as AngioDynamics, Avinger, Ra Medical Systems, REX Medical, and Cardio Flow compete through focused technology platforms and expanding regulatory clearances.

The competitive landscape can be evaluated across the following dimensions:

  • Market concentration: Highly consolidated, with a small number of major players holding the majority of global revenue.
  • Leading players: Medtronic, Boston Scientific, and Abbott anchor the top tier through extensive R&D and global distribution networks.
  • Geographic reach: Leaders operate global commercial infrastructure spanning North America, Europe, and Asia-Pacific.
  • Product portfolio strength: Top players offer multi-modality platforms spanning directional, rotational, orbital, and laser atherectomy.
  • Imaging integration: Combination of atherectomy with intravascular ultrasound, optical coherence tomography, and intravascular lithotripsy is a decisive competitive advantage.
  • Strategic partnerships and M&A: Active consolidation, including Abbott's acquisition of Cardiovascular Systems, Inc., extends technology reach and portfolio breadth.
  • Regulatory momentum: Ongoing approvals and label expansions, such as AngioDynamics' Auryon CE Mark and Avinger's Pantheris SV FDA clearance, extend addressable indications.
  • Innovation focus: Dual-function and multi-modality devices, AI-driven procedural guidance, and robotics-assisted intervention are key areas of competitive differentiation.

Atherectomy Devices Market Recent Developmental Activities

In January 2025, AngioDynamics, Inc., initiated a new clinical trial to expand the indications of its Auryon Atherectomy System to treat below-the-knee peripheral artery disease. Strategic significance: Broadens the addressable patient population for a leading laser atherectomy platform.

In January 2025, the FDA cleared a 510(k) submission for the Rotarex Atherectomy System, covering revised instructions for use aimed at reducing helix breakage. Strategic significance: Reinforces device reliability and sustains physician confidence in rotational atherectomy.

Atherectomy Devices Market Segmentation

Atherectomy Devices Market by Product

  • Directional Atherectomy Devices
  • Rotational Atherectomy Devices
  • Orbital Atherectomy Devices
  • Laser Atherectomy Devices

Atherectomy Devices Market by Application

  • Coronary Artery Disease
  • Peripheral Artery Disease
  • In-Stent Restenosis

Atherectomy Devices Market by End-User

  • Hospitals
  • Specialty Clinics
  • Others

Atherectomy Devices Market by Geography

  • North America Atherectomy Devices Market
  • United States Atherectomy Devices Market Size in USD million (2023-2034)
  • Canada Atherectomy Devices Market Size in USD million (2023-2034)
  • Mexico Atherectomy Devices Market Size in USD million (2023-2034)
  • Europe Atherectomy Devices Market
  • Germany Atherectomy Devices Market Size in USD million (2023-2034)
  • United Kingdom Atherectomy Devices Market Size in USD million (2023-2034)
  • France Atherectomy Devices Market Size in USD million (2023-2034)
  • Italy Atherectomy Devices Market Size in USD million (2023-2034)
  • Spain Atherectomy Devices Market Size in USD million (2023-2034)
  • Rest of Europe Atherectomy Devices Market Size in USD million (2023-2034)
  • Asia-Pacific Atherectomy Devices Market
  • China Atherectomy Devices Market Size in USD million (2023-2034)
  • Japan Atherectomy Devices Market Size in USD million (2023-2034)
  • India Atherectomy Devices Market Size in USD million (2023-2034)
  • Australia Atherectomy Devices Market Size in USD million (2023-2034)
  • South Korea Atherectomy Devices Market Size in USD million (2023-2034)
  • Rest of Asia-Pacific Atherectomy Devices Market Size in USD million (2023-2034)
  • Rest of the World (RoW) Atherectomy Devices Market
  • Middle East Atherectomy Devices Market Size in USD million (2023-2034)
  • Africa Atherectomy Devices Market Size in USD million (2023-2034)
  • South America Atherectomy Devices Market Size in USD million (2023-2034)

Key Takeaways from the Atherectomy Devices Market Report Study

  • Market size analysis for the current atherectomy devices market size (2025), and market forecast for 9 years (2026 to 2034).
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures that happened over the last 3 years.
  • Key companies dominating the global atherectomy devices market.
  • Various opportunities available for competitors in the atherectomy devices market space.
  • What are the top-performing segments in 2025? How will these segments perform in 2034?
  • Which are the top-performing regions and countries in the current atherectomy devices market scenario?
  • Which are the regions and countries where companies should concentrate their opportunities for atherectomy devices market growth in the future?

Target audience who can benefit from this atherectomy devices market report study

  • Atherectomy devices product providers
  • Research organizations and consulting companies
  • Atherectomy devices-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in atherectomy devices
  • Various end-users who want to know more about the atherectomy devices market and the latest technological developments in the atherectomy devices market.

Frequently Asked Questions:

Q1. What is the growth rate of the atherectomy devices market?

The atherectomy devices market is projected to expand at a CAGR of 8.5% during the forecast period from 2026-2034.

Q2. What is the market size of the atherectomy devices market?

The atherectomy devices market is estimated at USD 1.12 billion in 2025 and is projected to reach USD 2.34 billion by 2034.

Q3. Which region dominates the atherectomy devices market?

North America dominated the Atherectomy Devices market with a 42% share of global revenue in 2025, supported by a high cardiovascular disease burden, advanced catheterization infrastructure, and favorable reimbursement conditions. Asia-Pacific is the fastest-growing region over the forecast period.

Q4. What are the key drivers of the atherectomy devices market?

The principal drivers are the rising global burden of coronary and peripheral artery disease, with an estimated 200 million people living with coronary heart disease worldwide in 2024; growing preference for minimally invasive revascularization; continuous technological advancement in imaging-integrated and multi-modality devices; and accelerating regulatory approvals and label expansions.

Q5. Who are the major players in the atherectomy devices market?

The major players include Koninklijke Philips N.V., Medtronic PLC, Boston Scientific Corporation, AngioDynamics Inc., Abbott Laboratories, Avinger, BD, Ra Medical Systems, REX Medical, and Cardio Flow, Inc., among other active providers profiled in the Competitive Landscape section. Medtronic, Boston Scientific, and Abbott lead through broad product portfolios and global distribution networks.

Table of Contents

1. Atherectomy Devices Market Report Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Segmentation
  • 1.3 Market Assumptions

2. Atherectomy Devices Market Executive Summary

  • 2.1 Market at a Glance

3. Atherectomy Devices Market Key Factors Analysis

  • 3.1 Atherectomy Devices Market Drivers
    • 3.1.1 Rising Global Burden of Coronary and Peripheral Artery Disease
    • 3.1.2 Growing Preference for Minimally Invasive Revascularization
    • 3.1.3 Technological Advancements and Imaging Integration
    • 3.1.4 Accelerating Regulatory Approvals and Label Expansions
  • 3.2 Atherectomy Devices Market Restraints and Challenges
    • 3.2.1 High Cost of Devices and Procedures
    • 3.2.2 Risk of Complications and Restenosis
    • 3.2.3 Competition from Alternative Treatment Options
  • 3.3 Atherectomy Devices Market Opportunities
    • 3.3.1 Imaging Integration and Combination-Therapy Devices
    • 3.3.2 Emerging-Market and Outpatient Care Expansion

4. Impact Analysis: AI, Geopolitical, Trade, and Economic Developments

5. Regulatory Analysis

  • 5.1 United States
  • 5.2 Europe
  • 5.3 Japan
  • 5.4 China

6. Atherectomy Devices Market Porter's Five Forces Analysis

  • 6.1 Bargaining Power of Suppliers
  • 6.2 Bargaining Power of Buyers
  • 6.3 Threat of New Entrants
  • 6.4 Threat of Substitutes
  • 6.5 Competitive Rivalry

7. Atherectomy Devices Market Assessment

  • 7.1 By Product
    • 7.1.1 Directional Atherectomy Devices
    • 7.1.2 Rotational Atherectomy Devices
    • 7.1.3 Orbital Atherectomy Devices
    • 7.1.4 Laser Atherectomy Devices
  • 7.2 By Application
    • 7.2.1 Coronary Artery Disease
    • 7.2.2 Peripheral Artery Disease
    • 7.2.3 In-Stent Restenosis
  • 7.3 By End-User
    • 7.3.1 Hospitals
    • 7.3.2 Specialty Clinics
    • 7.3.3 Others
  • 7.4 By Geography
    • 7.4.1 North America
      • 7.4.1.1 United States Atherectomy Devices Market Size in USD million (2023-2034)
      • 7.4.1.2 Canada Atherectomy Devices Market Size in USD million (2023-2034)
      • 7.4.1.3 Mexico Atherectomy Devices Market Size in USD million (2023-2034)
    • 7.4.2 Europe
      • 7.4.2.1 Germany Atherectomy Devices Market Size in USD million (2023-2034)
      • 7.4.2.2 United Kingdom Atherectomy Devices Market Size in USD million (2023-2034)
      • 7.4.2.3 France Atherectomy Devices Market Size in USD million (2023-2034)
      • 7.4.2.4 Italy Atherectomy Devices Market Size in USD million (2023-2034)
      • 7.4.2.5 Spain Atherectomy Devices Market Size in USD million (2023-2034)
      • 7.4.2.6 Rest of Europe Atherectomy Devices Market Size in USD million (2023-2034)
    • 7.4.3 Asia-Pacific
      • 7.4.3.1 China Atherectomy Devices Market Size in USD million (2023-2034)
      • 7.4.3.2 Japan Atherectomy Devices Market Size in USD million (2023-2034)
      • 7.4.3.3 India Atherectomy Devices Market Size in USD million (2023-2034)
      • 7.4.3.4 Australia Atherectomy Devices Market Size in USD million (2023-2034)
      • 7.4.3.5 South Korea Atherectomy Devices Market Size in USD million (2023-2034)
      • 7.4.3.6 Rest of Asia-Pacific Atherectomy Devices Market Size in USD million (2023-2034)
    • 7.4.4 Rest of World
      • 7.4.4.1 Middle East Atherectomy Devices Market Size in USD million (2023-2034)
      • 7.4.4.2 Africa Atherectomy Devices Market Size in USD million (2023-2034)
      • 7.4.4.3 South America Atherectomy Devices Market Size in USD million (2023-2034)

8. Atherectomy Devices Market Competitive Landscape

  • 8.1 Market Concentration and Structure
  • 8.2 Competitive Positioning and Market Share Analysis (Premium Offering)

9. Atherectomy Devices Market Startup Funding and Investment Trends

10. Atherectomy Devices Market Company and Product Profiles

  • 10.1 Koninklijke Philips N.V.
    • 10.1.1 Company Overview
    • 10.1.2 Company Snapshot
    • 10.1.3 Financial Overview
    • 10.1.4 Service Portfolio
    • 10.1.5 Strategic Initiatives / Entropy
  • 10.2 Medtronic PLC
    • 10.2.1 Company Overview
    • 10.2.2 Company Snapshot
    • 10.2.3 Financial Overview
    • 10.2.4 Product Portfolio
    • 10.2.5 Strategic Initiatives / Entropy
  • 10.3 Boston Scientific Corporation
    • 10.3.1 Company Overview
    • 10.3.2 Company Snapshot
    • 10.3.3 Financial Overview
    • 10.3.4 Product Portfolio
    • 10.3.5 Strategic Initiatives / Entropy
  • 10.4 AngioDynamics Inc.
    • 10.4.1 Company Overview
    • 10.4.2 Company Snapshot
    • 10.4.3 Financial Overview
    • 10.4.4 Product Portfolio
    • 10.4.5 Strategic Initiatives / Entropy
  • 10.5 Abbott Laboratories
    • 10.5.1 Company Overview
    • 10.5.2 Company Snapshot
    • 10.5.3 Financial Overview
    • 10.5.4 Product Portfolio
    • 10.5.5 Strategic Initiatives / Entropy
  • 10.6 Avinger
    • 10.6.1 Company Overview
    • 10.6.2 Company Snapshot
    • 10.6.3 Financial Overview
    • 10.6.4 Product Portfolio
    • 10.6.5 Strategic Initiatives / Entropy
  • 10.7 BD
    • 10.7.1 Company Overview
    • 10.7.2 Company Snapshot
    • 10.7.3 Financial Overview
    • 10.7.4 Product Portfolio
    • 10.7.5 Strategic Initiatives / Entropy
  • 10.8 Ra Medical Systems
    • 10.8.1 Company Overview
    • 10.8.2 Company Snapshot
    • 10.8.3 Financial Overview
    • 10.8.4 Product Portfolio
    • 10.8.5 Strategic Initiatives / Entropy
  • 10.9 REX Medical
    • 10.9.1 Company Overview
    • 10.9.2 Company Snapshot
    • 10.9.3 Financial Overview
    • 10.9.4 Product Portfolio
    • 10.9.5 Strategic Initiatives / Entropy
  • 10.10 Cardio Flow, Inc.
    • 10.10.1 Company Overview
    • 10.10.2 Company Snapshot
    • 10.10.3 Financial Overview
    • 10.10.4 Product Portfolio
    • 10.10.5 Strategic Initiatives / Entropy

11. KOL Views

12. Project Approach

13. About DelveInsight

14. Disclaimer and Contact Us

List of Tables

  • Table 1: Atherectomy Devices Market in Global (2023-2034)
  • Table 2: Atherectomy Devices Market in Global by Product (2023-2034)
  • Table 3: Atherectomy Devices Market in Global by Application (2023-2034)
  • Table 4: Atherectomy Devices Market in Global by End-Users (2023-2034)
  • Table 5: Atherectomy Devices Market in Global by Geography (2023-2034)
  • Table 6: Atherectomy Devices Market in North America (2023-2034)
  • Table 7: Atherectomy Devices Market in the United States (2023-2034)
  • Table 8: Atherectomy Devices Market in Canada (2023-2034)
  • Table 9: Atherectomy Devices Market in Mexico (2023-2034)
  • Table 10: Atherectomy Devices Market in Europe (2023-2034)
  • Table 11: Atherectomy Devices Market in Germany (2023-2034)
  • Table 12: Atherectomy Devices Market in United Kingdom (2023-2034)
  • Table 13: Atherectomy Devices Market in France (2023-2034)
  • Table 14: Atherectomy Devices Market in Italy (2023-2034)
  • Table 15: Atherectomy Devices Market in Spain (2023-2034)
  • Table 16: Atherectomy Devices Market in the Rest of Europe (2023-2034)
  • Table 17: Atherectomy Devices Market in Asia-Pacific (2023-2034)
  • Table 18: Atherectomy Devices Market in China (2023-2034)
  • Table 19: Atherectomy Devices Market in Japan (2023-2034)
  • Table 20: Atherectomy Devices Market in India (2023-2034)
  • Table 21: Atherectomy Devices Market in Australia (2023-2034)
  • Table 22: Atherectomy Devices Market in South Korea (2023-2034)
  • Table 23: Atherectomy Devices Market in Rest of Asia-Pacific (2023-2034)
  • Table 24: Atherectomy Devices Market in the Rest of the World (2023-2034)
  • Table 25: Atherectomy Devices Market in the Middle East (2023-2034)
  • Table 26: Atherectomy Devices Market in Africa (2023-2034)
  • Table 27: Atherectomy Devices Market in South America (2023-2034)
  • Table 28: Competitive Landscape
  • Table 29: Startup Funding and Investment Trends

List of Figures

  • Figure 1: Atherectomy Devices Market Drivers
  • Figure 2: Atherectomy Devices Market Restraints
  • Figure 3: Atherectomy Devices Market Opportunities
  • Figure 4: Impact Analysis: AI, Geopolitical, Trade, and Economic Developments
  • Figure 5: Regulatory Analysis (US, EU, Japan, China)
  • Figure 6: Porter's Five Forces Analysis
  • Figure 7: Competitive Analysis
  • Figure 8: Atherectomy Devices Market in Global (2023-2034)
  • Figure 9: Atherectomy Devices Market in Global by Product (2023-2034)
  • Figure 10: Atherectomy Devices Market in Global by Application (2023-2034)
  • Figure 11: Atherectomy Devices Market in Global by End-Users (2023-2034)
  • Figure 12: Atherectomy Devices Market in Global by Geography (2023-2034)
  • Figure 13: Atherectomy Devices Market in North America (2023-2034)
  • Figure 14: Atherectomy Devices Market in the United States (2023-2034)
  • Figure 15: Atherectomy Devices Market in Canada (2023-2034)
  • Figure 16: Atherectomy Devices Market in Mexico (2023-2034)
  • Figure 17: Atherectomy Devices Market in Europe (2023-2034)
  • Figure 18: Atherectomy Devices Market in Germany (2023-2034)
  • Figure 19: Atherectomy Devices Market in United Kingdom (2023-2034)
  • Figure 20: Atherectomy Devices Market in France (2023-2034)
  • Figure 21: Atherectomy Devices Market in Italy (2023-2034)
  • Figure 22: Atherectomy Devices Market in Spain (2023-2034)
  • Figure 23: Atherectomy Devices Market in the Rest of Europe (2023-2034)
  • Figure 24: Atherectomy Devices Market in Asia-Pacific (2023-2034)
  • Figure 25: Atherectomy Devices Market in China (2023-2034)
  • Figure 26: Atherectomy Devices Market in Japan (2023-2034)
  • Figure 27: Atherectomy Devices Market in India (2023-2034)
  • Figure 28: Atherectomy Devices Market in Australia (2023-2034)
  • Figure 29: Atherectomy Devices Market in South Korea (2023-2034)
  • Figure 30: Atherectomy Devices Market in Rest of Asia-Pacific (2023-2034)
  • Figure 31: Atherectomy Devices Market in the Rest of the World (2023-2034)
  • Figure 32: Atherectomy Devices Market in the Middle East (2023-2034)
  • Figure 33: Atherectomy Devices Market in Africa (2023-2034)
  • Figure 34: Atherectomy Devices Market in South America (2023-2034)
  • Figure 35: Competitive Landscape
  • Figure 36: Startup Funding and Investment Trends